137 related articles for article (PubMed ID: 16385491)
1. New prospects for autoimmune disease therapy: B cells on deathwatch.
St Clair EW; Tedder TF
Arthritis Rheum; 2006 Jan; 54(1):1-9. PubMed ID: 16385491
[No Abstract] [Full Text] [Related]
2. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
Browning JL
Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
[TBL] [Abstract][Full Text] [Related]
3. B cell-ablative therapy for the treatment of autoimmune diseases.
Patel DD
Arthritis Rheum; 2002 Aug; 46(8):1984-5. PubMed ID: 12209499
[No Abstract] [Full Text] [Related]
4. [Disorders of cellular immunity in systemic scleroderma].
Sierakowski SJ; Kucharz EJ
Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
[No Abstract] [Full Text] [Related]
5. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes in nonorgan-specific autoimmune diseases: implications for therapy.
Youinou P; Pers JO
Lupus; 2012 Nov; 21(13):1375-7. PubMed ID: 22976931
[No Abstract] [Full Text] [Related]
7. Systemic sclerosis up to date.
Takehara K
J Dermatol; 2010 Jan; 37(1):2. PubMed ID: 20175835
[No Abstract] [Full Text] [Related]
8. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
9. [Anti-B-cell strategies in autoimmune diseases].
Müller-Ladner U
Z Rheumatol; 2009 Jul; 68(5):363. PubMed ID: 19513728
[No Abstract] [Full Text] [Related]
10. B cell depletion therapy in rheumatic disease.
Edwards JC; Cambridge G; Leandro MJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
[TBL] [Abstract][Full Text] [Related]
11. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
Stübgen JP
J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
[TBL] [Abstract][Full Text] [Related]
12. B cell depletion: on the rise.
Hinze CH; Grom AA
J Pediatr; 2007 Apr; 150(4):335-7. PubMed ID: 17382106
[No Abstract] [Full Text] [Related]
13. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
14. Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
Simms RW; Lafyatis R
Rheumatology (Oxford); 2010 Feb; 49(2):201-2. PubMed ID: 20032221
[No Abstract] [Full Text] [Related]
15. [B-cell-directed therapy in patients with connective tissue diseases].
Jacobi AM; Dörner T
Dtsch Med Wochenschr; 2012 Sep; 137(36):1755-7. PubMed ID: 22933200
[TBL] [Abstract][Full Text] [Related]
16. Rituximab: a B-cell depletion therapy for dermatologic disease.
Prajapati V; Mydlarski PR
Skin Therapy Lett; 2007; 12(6):6-9. PubMed ID: 17762903
[TBL] [Abstract][Full Text] [Related]
17. B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
Edwards JC; Cambridge G
Nat Rev Immunol; 2006 May; 6(5):394-403. PubMed ID: 16622478
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
[TBL] [Abstract][Full Text] [Related]
19. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
Sun J; Lin Z; Feng J; Li Y; Shen B
Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
[TBL] [Abstract][Full Text] [Related]
20. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis.
Taylor RP; Lindorfer MA
Nat Clin Pract Rheumatol; 2007 Feb; 3(2):86-95. PubMed ID: 17299446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
